ERBB2 and breast cancer: Based on our pharmacological findings via the combinatorial treatment with the iron chelator, DFP, and lapatinib, and given STEAP4’s role in intracellular iron import, we hypothesize that the mitochondrial iron pathway plays a potentially critical and understudied role in the pathogenesis and/or progression of HER2+ BC.